Amino-glutethimide and Pregnancy

JAMA: The Journal of the American Medical Association

Volumn 230, Issue 7, 1974, Pages 963-964

  Hanson, Thomas J ^a   Ballonoff, Larry B ^a   Northcutt, Robert C ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; STEROID;

ADRENAL HYPERPLASIA; ORAL DRUG ADMINISTRATION; PREGNANCY; THERAPY; VIRILIZATION; ADULT; ARTICLE; CUSHING SYNDROME; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; GESTATIONAL AGE; HUMAN; NEWBORN;

ADULT; AMINOGLUTETHIMIDE; CUSHING SYNDROME; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 0016332613     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1974.03240070015012     Document Type: Letter

References (6)

1. 1. Horky K, Kuchel O, Gregorová I, et al: Effect of aminoglutethimide on urinary steroid excretion in patients with congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency. Metabolism 21:305-312, 1972.
2. 2. Faglia G, Gattinoni L, Travaglini P, et al: Evidence suggesting 11 β-hydroxylase inhibition during aminoglutethimide administration. Metabolism 20:266-272, 1971.
3. 3. Iffy L, Ansell J, Bryant J, et al: Nonadrenal female pseudohermaphroditism: An unusual case of fetal masculinization. Obstet Gynecol 26:59-65, 1965.
4. 4. LeMaire W, Cleveland W, Bejar R, et al: Aminoglutethimide: A possible cause of psydohermaphroditism in females. Am J Dis Child 124:421-423, 1972.
5. 5. Marek J, Horky K: Aminoglutethimide administration in pregnancy. Lancet 2:1312-1313, 1970.
6. 6. Goldman A: Experimental lipoid adrenal hyperplasia: Prevention of anatomic defect produced by aminoglutethimide. Endocrinology 87:889-893, 1970.